Physician profile
Luke Macyszyn
NPI 1225291842
$177,903.40
in general payments reported to CMS, 2019-2025
41 companies · $1,288 in 2025
The $1,288 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $69K · 2021: $28K · 2022: $17K · 2023: $14K · 2024: $6,834 · 2025: $1,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $5,582 · Travel and Lodging: $3,561 · Honoraria: $1,000 · Acquisitions: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,875.00 |
| Food and Beverage | $5,582.43 |
| Travel and Lodging | $3,560.99 |
| Honoraria | $1,000.00 |
| Acquisitions | $244.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $81,622.23 | 2019-2021 | |
| Medical Device Business Services, INC. | $18,849.66 | 2019-2021 | |
| Orthofix Medical, INC. | $12,615.42 | 2020-2024 | 3 Degree, Pillar Sa |
| Nuvasive, INC. | $10,535.43 | 2021-2023 | Pulse, Reline, Xlif |
| Depuy Synthes Products, INC. | $9,028.91 | 2020-2023 | Fibulink |
| Medicrea USA, Corp. | $8,271.91 | 2019 | |
| Brainlab, INC. | $7,562.42 | 2019-2023 | Image Guided Surgical Device |
| Ethicon INC. | $5,565.00 | 2020-2022 | |
| Prosidyan, INC | $4,888.13 | 2021 | |
| Depuy Synthes Sales INC. | $4,142.79 | 2019-2022 | |
| Globus Medical, INC. | $2,069.58 | 2024-2025 | Excelsiusgps Robotic Navigation System, Excelsius Gps, Creo |
| Integrity Implants INC. | $2,058.40 | 2021-2022 | |
| Saxum Surgical, INC. | $1,659.95 | 2023-2024 | |
| Mirus, LLC | $1,446.97 | 2022 | |
| Arthrex, INC. | $1,365.34 | 2023-2024 | Spine Instruments Endoscopic Instrument Sets |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $956.29 | 2023-2024 | |
| Ethicon US, LLC | $849.94 | 2019-2021 | |
| Alphatec Spine, INC | $645.41 | 2022 | |
| Spineart USA INC | $543.28 | 2025 | Scarlet Ac-T, Scarlet Al-T |
| Stryker Corporation | $539.10 | 2019-2023 | Airo |
| Medtronic, INC. | $423.24 | 2023-2024 | Unid_pass, Mazor X System |
| Cerapedics INC. | $405.17 | 2022 | |
| Adcura, INC. | $349.26 | 2023 | |
| Happe Spine | $275.58 | 2025 | Integrate-C |
| Carbofix Spine INC | $171.42 | 2022 | |
| Intrinsic Therapeutics | $149.69 | 2023 | Barricaid Acd (Annular Closure Device) |
| Highridge Medical LLC | $146.03 | 2024 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Nalu Medical, INC. | $131.26 | 2023-2024 | Nalu Neurostimulation System |
| Innovasis INC | $96.34 | 2019 | |
| Stimwave Technologies Incorporated | $93.60 | 2020 | |
| Ziehm-Orthoscan, INC. | $72.02 | 2019 | |
| Misonix INC | $66.28 | 2019 | |
| Integrity Implants INC. Dba Accelus | $62.64 | 2023 | |
| Surgical Theater. INC. | $58.51 | 2023 | |
| Radius Health, INC. | $44.78 | 2019 | |
| Boston Scientific Corporation | $30.49 | 2023 | |
| Baxter Healthcare | $29.31 | 2023 | Floseal |
| Vertex Pharmaceuticals Incorporated | $28.29 | 2025 | |
| Abbott Laboratories | $20.04 | 2024 | Eterna |
| Lemaitre Vascular, INC. | $16.70 | 2019 | |
| Aesculap, INC. | $16.59 | 2025 | Elan 4 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,262.50 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$3,750.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Macyszyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.